Susan Hasty, Publisher
Table of Contents . . . August 13th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS Therapies - Nevirapine Linked To Liver Damage
HIV Testing - Novel Assay Superior For Subtyping African Strains
AIDS Therapies - Structural Basis Found For NNRTI Cross-Resistance
HIV Complications - Diarrhea May Be Linked To Fat Malabsorption
HIV Complications - Infected Women May Be At Higher Risk For Anal Cancers
Hemophilia - Study Looks At Genomic Variability Of Hepatitis C In Patients Coinfected With HCV/HIV
Pathogenesis - Minor Mutations In HIV Virus Have Major Impact
Vaccine Development - First Vaccine Developed That Protects Against SIV In Monkeys
AIDS Therapies - Comparing Lamivudine To Emtricitabine Influenced By Cell Line
AIDS Therapies - Efavirenz Provides Greater Long-Term Viral Suppression
AIDS Therapies - Hypersusceptibility To Drugs Leads To Improved Patient Outcomes
AIDS Therapies - Initiative Targets 'Orphan Genes' For Drug Development
AIDS Therapies - Multidrug Transporters Can Reduce Protease Inhibitor Levels
AIDS Therapies - Nevirapine Combination Matches Protease-Inhibitor-Based Regimen
AIDS Therapies - No HIV Mutation Found After Long-Term Treatment With Immune Therapy
AIDS Therapies - Non-Peptidic Protease Inhibitor Suppresses HIV In Resistant Patients
AIDS Therapies - Once-Daily Didanosine Is Safe, Effective, And Convenient
Blood Transfusion - Leukoreduction Does Not Affect Transfusion Need
HIV Complications - Tuberculosis-Related Chemokine Disturbance May Hasten Progression
HIV Immunotherapy - Clinical Trial Findings Show Remune Has "Significant Effect" On Viral Load
HIV Testing - Tampon Eluents Can Be Used As Samples
HIV Transmission - Prevention Program For Ivory Coast Sex Workers Successful
Lipodystrophy Syndrome - Researcher Proposes Definition Of HIV Associated Condition
Sexually Transmitted Disease - U.K. Public Health Officials Call For Awareness Campaigns To Combat Soaring STD Rates
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.